Parviz Shamlou, PhD, the George B. and Joy Rathmann Professor of Bioprocessing and director of the Amgen Center for Bioprocessing at the Keck Graduate Institute, has been appointed executive director and head of the Jefferson Institute for Bioprocessing at Thomas Jefferson University.

“Parviz Shamlou’s impressive academic and industry experiences make him the perfect choice as inaugural executive director of the Jefferson Institute for Bioprocessing,” said Ronald Kander, PhD, dean of the Kanbar College of Design, Engineering and Commerce and associate provost for applied research at Jefferson. “His technical knowledge of bioprocessing and dynamic leadership abilities will help us accomplish our vision for the Institute to provide unique education, training and workforce development opportunities for our students, the biopharmaceutical industry and the region.”

Opening this spring, the Institute will provide education and training in biopharmaceutical processing.

Previous articleBristol-Myers Squibb to Acquire Celgene for $74B
Next articleOptogenetics Green Lights Bladder Control Therapy